| Foreword | 41.4 KB |
| Research Programmes | 43.7 KB |
| Molecular Oncology Programme | 3.5 MB |
| Telomeres and Telomerase Group | 367.6 KB |
| Experimental Oncology Group | 482 KB |
| Cell Division and Cancer Group | 360.3 KB |
| Signalling and Cell Cycle Group | 307.6 KB |
| Tumour Suppression Group | 414.5 KB |
| Genomic Instability Junior Group | 284.6 KB |
| Chromosome Dynamics Junior Group | 286.8 KB |
| DNA Replication Junior Group | 264.8 KB |
| Cell Competition Junior Group | 252.1 KB |
| DNA Hypermutation and Cancer Junior Group | 467.4 KB |
| Structural Biology and Biocomputing Programme | 2.1 MB |
| Structural Computational Biology Group | 468.5 KB |
| Macromolecular Crystallography Group | 459.1 KB |
| Computational Biophysics Junior Group | 271.1 KB |
| Cell Signalling and Adhesion Junior Group | 256.1 KB |
| Spectroscopy and Nuclear Magnetic Resonance Core Unit | 200.3 KB |
| Bioinformatics Core Unit | 153.7 KB |
| National Bioinformatics Institute Core Unit | 240 KB |
| BBVA Foundation - CNIO Cancer Cell Biology Programme | 1.2 MB |
| Genes, Development and Disease Group | 433.1 KB |
| Epithelial Cell Biology Junior Group | 255.8 KB |
| Growth Factors, Nutrients and Cancer Junior Group | 168.5 KB |
| Molecular Pathology Programme | 2.5 MB |
| Lymphoma Group | 422.7 KB |
| Epithelial Carcinogenesis Group | 362.1 KB |
| Melanoma Group | 409.5 KB |
| Tumour Markers Junior Group | 355.5 KB |
| Molecular Diagnostics Core Unit | 236.1 KB |
| Tumour Bank Core Unit | 195.6 KB |
| Human Cancer Genetics Programme | 2 MB |
| Human Genetics Group | 412.9 KB |
| Molecular Cytogenetics Group | 346 KB |
| Genetic and Molecular Epidemiology Group | 333.5 KB |
| Hereditary Endocrine Cancer Group | 416.8 KB |
| Human Genotyping-CEGEN Core Unit | 201 KB |
| Experimental Therapeutics Programme | 2.2 MB |
| High Throughput Screening Section | 227.2 KB |
| Assay Development Section | 235.4 KB |
| Biochemistry Section | 194.8 KB |
| Animal Pharmacology Section | 228.3 KB |
| Cell Signalling Therapies Section | 352.5 KB |
| In Vivo Target Validation Section | 211.8 KB |
| Medicinal Chemistry Department | 142.2 KB |
| Medicinal Chemistry I and Analytical Chemistry Section | 249.7 KB |
| Medicinal Chemistry II Section | 231.8 KB |
| Computational Chemistry and Chemoinformatics Section | 180.7 KB |
| Biotechnology Programme | 2.1 MB |
| Proteomics Core Unit | 196.5 KB |
| Comparative Pathology Core Unit | 347.5 KB |
| Genomics Core Unit | 308.3 KB |
| Confocal Microscopy Core Unit | 230.4 KB |
| Molecular Imaging Core Unit | 181.2 KB |
| Transgenic Mice Core Unit | 185.2 KB |
| Monoclonal Antibodies Core Unit | 235.2 KB |
| Histology and Immunohistochemistry Core Unit | 222.9 KB |
| Flow Cytometry Core Unit | 211.9 KB |
| Clinical Research Programme | 1.1 MB |
| Gastrointestinal Cancer Clinical Research Unit | 348.5 KB |
| Stem Cells and Cancer Group | 456.8 KB |
| Animal Facility | 530.5 KB |
| Genetically Modified Mouse Strains | 77.2 KB |
| Facts and Figures | 2.5 MB |
| Scientific Productivity | 122.2 KB |
| Awards and Recognition | 42.9 KB |
| Training Programmes and Courses | 144.4 KB |
| Conferences, Workshops and Seminars | 259.5 KB |
| Collaborating Institutions | 71.2 KB |
| Competitive Funding | 63.7 KB |
| Philanthropy and Private Sponsors | 187.1 KB |
| Administration | 330.6 KB |